Aeglea Biotherapeutics shares owned by Ensign Peak Advisors
Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by Ensign Peak Advisors
from 13F filings
Historical chart of Ensign Peak Advisors investment in Aeglea Biotherapeutics
Tip: Access up to 7 years of quarterly data
All positions including Aeglea Biotherapeutics held by Ensign Peak Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Aeglea Biotherapeutics by Ensign Peak Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $7.5M | 149k | 50.44 |
| 2024-12-31 | $1.9M | 83k | 23.28 |
| 2024-09-30 | $2.4M | 83k | 29.41 |
| 2024-06-30 | $1.9M | 83k | 23.51 |